UBS analyst Eliana Merle initiated coverage of Ascendis Pharma (ASND) with a Buy rating and $196 price target UBS thinks the next 1-3 years ...

UBS lowered the firm’s price target on CDW (CDW) to $220 from $233 and keeps a Buy rating on the shares. The dropped the price target to ...

The Swiss bank engaged in a “pattern of obstruction” by not sharing some information during past investigations into the ...

Along with the Sense Pro, Schlage also announced a new entry-level smart lock. The $199 Schlage Arrive Smart WiFi Deadbolt ...

Central to the refresh are new logos for the upscale and upper-upscale Radisson, Radisson Blu and Radisson Individuals brands ...